Creative Biolabs-Immuno-oncology

Red Blood Cell Immunophenotyping Service

Background Service Highlights FAQs Contact Us

Introduction: The Imperative of Red Blood Cell Characterization

Red blood cells (RBCs) are fundamental to oxygen transport and overall physiological homeostasis. Their surface is adorned with a diverse array of antigens, comprising various blood group systems, whose precise identification is paramount for ensuring transfusion safety, diagnosing hematological disorders, and guiding therapeutic strategies. Red Blood Cell (RBC) Immunophenotyping is a sophisticated laboratory technique dedicated to identifying and quantifying these specific antigens. This intricate analysis is not merely a diagnostic step but a cornerstone in modern transfusion medicine, significantly mitigating risks such as alloimmunization and enabling the provision of optimally matched blood products. Beyond transfusion applications, the comprehensive immunophenotypic analysis of RBCs contributes profoundly to the diagnosis and monitoring of complex diseases, including leukemias and lymphomas, underscoring its broad biological significance.

At Creative Biolabs, with over two decades of specialized expertise in biological diagnostics and a deep commitment to advancing patient care, we recognize the critical importance of meticulous RBC characterization. Our integrated approach to RBC immunophenotyping leverages cutting-edge technology and unparalleled scientific acumen to deliver precise, actionable insights.

Fig.1 Red blood cells interact with the relevant cells or components in vessel. (OA Literature)Fig.1 The relevant cells or components that interact with red blood cells in vessel.1

Our Red Blood Cell Immunophenotyping Service

Creative Biolabs' Red Blood Cell Immunophenotyping Service represents the pinnacle of diagnostic excellence, designed to meet the rigorous demands of clinical practice, pharmaceutical research, and drug development. For over 20 years, Creative Biolabs has been a trusted partner in the biological industry, consistently providing reliable and accurate data. Our service is built on the philosophy that precise cellular characterization is the foundation for effective patient management and scientific discovery. We understand the complexities inherent in red blood cell biology and the nuances required for accurate antigen identification and functional assessment. Creative Biolabs' commitment extends to minimizing the risk of alloimmunization, identifying challenging antibody specificities, and supporting the development of novel therapies for blood disorders. By integrating advanced technologies with our extensive expertise, Creative Biolabs ensures that our clients receive the highest quality of service, translating into improved patient outcomes and accelerated research initiatives.

Comprehensive Service Content

Creative Biolabs offers a multifaceted suite of services encompassing both RBC marker detection and functional assays, providing a holistic view of red blood cell health and behavior.

Red Blood Cell Marker Detection

Our marker detection capabilities are designed for granular identification of RBC surface antigens and associated genetic predispositions:

Antibody Screening and Identification: A critical component for transfusion safety and prenatal care, this service meticulously detects the presence of irregular antibodies in patient or donor plasma that could potentially react with transfused RBCs.

RBC Genotyping: Going beyond traditional serological phenotyping, Creative Biolabs utilizes advanced genetic testing to ascertain the precise allelic variations encoding specific blood group antigens. This is particularly invaluable in scenarios where serological results are ambiguous or unreliable, such as in recently transfused patients where transfused cells can mask the recipient's true phenotype, in individuals with a positive Direct Antiglobulin Test (DAT), or when certain medications interfere with antibody binding.

Flow Cytometry for Comprehensive Marker Analysis: Utilizing state-of-the-art flow cytometry, Creative Biolabs can rapidly analyze multiple physical and fluorescent characteristics of individual RBCs. This enables the quantification of various surface markers, assessment of intracellular components, and identification of subtle shifts in RBC populations, providing deeper insights into cellular states in both healthy and diseased conditions.

Red Blood Cell Functional Tests

Beyond mere antigen presence, Creative Biolabs' functional assays delve into the dynamic physiological properties of RBCs, offering a deeper understanding of their performance in various conditions:

Flow Adhesion Assay: Understanding the adhesive properties of RBCs, particularly their interaction with the vascular endothelium under physiological shear stress, is paramount in conditions like SCD where increased adhesion contributes to vaso-occlusion. Creative Biolabs' flow adhesion assay precisely quantifies these interactions, allowing for the study of cellular adherence mechanisms and the evaluation of therapeutic agents designed to mitigate pathological adhesion. This also extends to understanding inflammatory cell recruitment, as demonstrated in studies utilizing flow adhesion assays to observe leukocyte recruitment to endothelial monolayers under shear stress.

Traditional Blood Rheology Assays: These assays analyze the macroscopic flow characteristics and deformation behavior of whole blood, providing comprehensive insights into its viscosity and flow properties. Such analyses are invaluable for assessing overall blood health and identifying rheological impairments that may contribute to microcirculatory complications.

RBC Survival Tests: To evaluate conditions associated with premature red cell destruction (hemolysis), Creative Biolabs conducts RBC survival tests. By labeling a patient's own red cells with a traceable marker, we can precisely measure their lifespan in circulation, aiding in the diagnosis and monitoring of various hemolytic anemias and other hematologic conditions.

Functional Assays in Immune-Mediated Destruction: Creative Biolabs employs a suite of assays to elucidate immune-mediated RBC destruction. The Monocyte Monolayer Assay (MMA), for instance, is a highly predictive test that assesses the capacity of a patient's monocytes to phagocytose antibody-sensitized RBCs, thereby predicting the clinical significance of irregular antibodies and the likelihood of in vivo hemolysis. Other relevant tests include chemiluminescence assays and antibody-dependent cellular cytotoxicity (ADCC) assays.

Our Advantages

Choosing Creative Biolabs for your Red Blood Cell Immunophenotyping needs provides a distinct advantage rooted in our specialized capabilities and unwavering commitment to excellence:

FAQs

Q1: What is the primary benefit of performing RBC functional tests in drug development?

A1: RBC functional tests, such as the Flow Adhesion Assay, provide critical insights into how novel therapeutic compounds impact the physiological properties of red blood cells. These assays allow researchers to assess a drug's mechanism of action, evaluate its efficacy in improving RBC health and function (e.g., reducing sickling or adhesion), and understand potential side effects, thus accelerating the preclinical and clinical development phases.

Q2: How does Creative Biolabs ensure the accuracy and reliability of its RBC immunophenotyping results?

A2: Creative Biolabs employs a multi-pronged approach to ensure accuracy and reliability. This includes utilizing validated, state-of-the-art technologies (e.g., advanced flow cytometry, molecular platforms), rigorous internal quality control measures, adherence to international quality standards, and the expertise of our highly experienced team. Our integration of AI tools further enhances diagnostic precision by automating complex analyses and minimizing human variability.

Contact Us

For detailed inquiries regarding Creative Biolabs' Red Blood Cell Immunophenotyping Service, to discuss specific project requirements, or to explore how our expertise can benefit your research, please reach out to our team of specialists.

Reference

  1. Pretini, Virginia et al. "Red Blood Cells: Chasing Interactions." Frontiers in physiology vol. 10 945. 31 Jul. 2019, doi:10.3389/fphys.2019.00945. Distributed under Open Access License CC BY 4.0, without modification.

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.